Literature DB >> 19916898

3D-FLAIR MRI in facial nerve paralysis with and without audio-vestibular disorder.

Seiichi Nakata1, Terukazu Mizuno, Shinji Naganawa, Makoto Sugiura, Tadao Yoshida, Masaaki Teranishi, Michihiko Sone, Tsutomu Nakashima.   

Abstract

CONCLUSION: Among patients with facial nerve paralysis, significant difference was observed on three-dimensional fluid-attenuated inversion recovery magnetic resonance imaging (3D-FLAIR MRI) between those with and without audio-vestibular disturbance. This MRI technique may contribute to elucidation of the pathology of Ramsay Hunt syndrome and Bell's palsy.
OBJECTIVE: To evaluate the 3D-FLAIR MRI findings in patients who have facial nerve paralysis with and without audio-vestibular disturbance.
METHODS: 3D-FLAIR MRI was performed with and without gadolinium enhancement in 15 patients (5 men and 10 women) with unilateral facial nerve paralysis: 3 patients with Ramsay Hunt syndrome, 3 patients having facial nerve paralysis with hearing loss or vertigo without vesicles, and 9 patients with Bell's palsy.
RESULTS: Five of the six patients with audio-vestibular disturbance showed high signals in the inner ear on precontrast 3D-FLAIR. In comparison, among nine patients with Bell's palsy, only one patient showed high signals in the inner ear on precontrast 3D-FLAIR (p < 0.05).

Entities:  

Mesh:

Year:  2010        PMID: 19916898     DOI: 10.3109/00016480903338123

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  9 in total

1.  Superior vestibular neuritis: improved detection using FLAIR sequence with delayed enhancement (1 h).

Authors:  Aina Venkatasamy; Tri Thai Huynh; Nathan Wohlhuter; Hella Vuong; Dominique Rohmer; Anne Charpiot; Nicolas Meyer; Francis Veillon
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-09-17       Impact factor: 2.503

2.  Feasibility of three-dimensional fluid-attenuated inversion recovery magnetic resonance imaging as a prognostic factor in patients with sudden hearing loss.

Authors:  Ho Yun Lee; Su Young Jung; Moon Suh Park; Seung Geun Yeo; So Yoon Lee; Sun Kyu Lee
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-11-15       Impact factor: 2.503

3.  Clinical manifestations in patients with herpes zoster oticus.

Authors:  Dong Hyuk Shin; Bo-Ram Kim; Jung Eun Shin; Chang-Hee Kim
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-08-26       Impact factor: 2.503

4.  Imaging of facial neuritis using T2-weighted gradient-echo fast imaging employing steady-state acquisition after gadolinium injection.

Authors:  Magali Hector; Ahmad Alnadji; Francis Veillon; Maher Abu Eid; Anne Charpiot; Christian Debry; Aïna Venkatasamy
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-09-22       Impact factor: 2.503

5.  Atypical clinical manifestations of herpes zoster oticus: diagnostic usefulness of magnetic resonance imaging.

Authors:  Jin Woo Choi; Hyunjoo Nahm; Jung Eun Shin; Chang-Hee Kim
Journal:  J Neurovirol       Date:  2019-07-05       Impact factor: 3.739

6.  Characteristics of hearing loss in patients with herpes zoster oticus.

Authors:  Chang-Hee Kim; Hyerang Choi; Jung Eun Shin
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

7.  Mastoid effusion on temporal bone MRI in patients with Bell's palsy and Ramsay Hunt syndrome.

Authors:  Jin Woo Choi; Jiyeon Lee; Dong-Han Lee; Jung Eun Shin; Chang-Hee Kim
Journal:  Sci Rep       Date:  2021-02-04       Impact factor: 4.379

8.  MRI With Gadolinium as a Measure of Blood-Labyrinth Barrier Integrity in Patients With Inner Ear Symptoms: A Scoping Review.

Authors:  Christopher I Song; Jacob M Pogson; Nicholas S Andresen; Bryan K Ward
Journal:  Front Neurol       Date:  2021-05-20       Impact factor: 4.003

9.  High-frequency ultrasound as an adjunct to neural electrophysiology: Evaluation and prognosis of Bell's palsy.

Authors:  Shuo Li; Rui-Jun Guo; Xiao-Ning Liang; Yue Wu; Wen Cao; Zhen-Ping Zhang; Wei Zhao; Hai-Dong Liang
Journal:  Exp Ther Med       Date:  2015-11-18       Impact factor: 2.447

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.